Cargando…

Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women

OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014...

Descripción completa

Detalles Bibliográficos
Autores principales: de Medeiros, Sebastião Freitas, Ormond, Cinthia Marenza, de Medeiros, Matheus Antônio Souto, de Souza Santos, Nayara, Banhara, Camila Regis, Yamamoto, Márcia Marly Winck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592777/
https://www.ncbi.nlm.nih.gov/pubmed/28784626
http://dx.doi.org/10.1530/EC-17-0151
_version_ 1783262940052324352
author de Medeiros, Sebastião Freitas
Ormond, Cinthia Marenza
de Medeiros, Matheus Antônio Souto
de Souza Santos, Nayara
Banhara, Camila Regis
Yamamoto, Márcia Marly Winck
author_facet de Medeiros, Sebastião Freitas
Ormond, Cinthia Marenza
de Medeiros, Matheus Antônio Souto
de Souza Santos, Nayara
Banhara, Camila Regis
Yamamoto, Márcia Marly Winck
author_sort de Medeiros, Sebastião Freitas
collection PubMed
description OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014 and July 2016, and 91 normal cycling healthy women, 46 normoandrogenemic and 147 hyperandrogenemic, patients with polycystic ovary syndrome (PCOS) were enrolled according to the Rotterdam criteria. Several anthropometric, biochemical and hormonal parameters were properly verified and correlated with 17-hydroxypregnenolone (17-OHPE) concentrations. RESULTS: 17-OHPE was higher in hyperandrogenemic PCOS than in normoandrogenemic PCOS and in control groups (P = 0.032 and P < 0.001, respectively). In healthy controls, 17-OHPE was positively associated with glucose, free estrogen index, DHEAS and negatively associated with compounds S. In normoandrogenemic PCOS patients, 17-OHPE presented positive correlations with VAI, LAP, cortisol, insulin and HOMA-IR. In the hyperandrogenemic group, 17-OHPE presented significant negative correlations with most anthropometric parameters, HOMA-IR, HOMA %B, estradiol, free estrogen index (FEI), C-peptide, and TG levels and positive correlations with HOMA-S and high-density lipoprotein cholesterol (HDL-C), sex-hormone binding globulin (SHBG), androstenedione (A4) and dehydroepiandrosterone (DHEA). Regarding hyperandrogenemic PCOS, and using a stepwise multiple regression, only HOMA-S and WHR were retained in the model (R(2) = 0.294, P < 0.001). CONCLUSION: 17-OHPE exhibited different relationships with anthropometric, and biochemical parameters in PCOS patients, depending on the androgen levels. In PCOS subjects with high androgen concentrations, 17-OHPE was negatively associated with most anthropometric parameters, particularly with those used as markers of adipose tissue dysfunction and frequently employed as predictors of cardiovascular disease risk; otherwise, 17-OHPE was positively associated with HDL-C and HOMA-S in this patients. Future studies are required to evaluate the clinical implications of these novel findings.
format Online
Article
Text
id pubmed-5592777
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Bioscientifica Ltd
record_format MEDLINE/PubMed
spelling pubmed-55927772017-09-18 Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women de Medeiros, Sebastião Freitas Ormond, Cinthia Marenza de Medeiros, Matheus Antônio Souto de Souza Santos, Nayara Banhara, Camila Regis Yamamoto, Márcia Marly Winck Endocr Connect Research OBJECTIVE: To examine the anthropometric, and metabolic connections of 17-hydroxypregnenolone in the normo- and hyperandrogenemic polycystic ovary syndrome phenotypes. MATERIALS AND METHODS: This cohort study was conducted at the Julio Muller University Hospital, Cuiabá, Brazil, between January 2014 and July 2016, and 91 normal cycling healthy women, 46 normoandrogenemic and 147 hyperandrogenemic, patients with polycystic ovary syndrome (PCOS) were enrolled according to the Rotterdam criteria. Several anthropometric, biochemical and hormonal parameters were properly verified and correlated with 17-hydroxypregnenolone (17-OHPE) concentrations. RESULTS: 17-OHPE was higher in hyperandrogenemic PCOS than in normoandrogenemic PCOS and in control groups (P = 0.032 and P < 0.001, respectively). In healthy controls, 17-OHPE was positively associated with glucose, free estrogen index, DHEAS and negatively associated with compounds S. In normoandrogenemic PCOS patients, 17-OHPE presented positive correlations with VAI, LAP, cortisol, insulin and HOMA-IR. In the hyperandrogenemic group, 17-OHPE presented significant negative correlations with most anthropometric parameters, HOMA-IR, HOMA %B, estradiol, free estrogen index (FEI), C-peptide, and TG levels and positive correlations with HOMA-S and high-density lipoprotein cholesterol (HDL-C), sex-hormone binding globulin (SHBG), androstenedione (A4) and dehydroepiandrosterone (DHEA). Regarding hyperandrogenemic PCOS, and using a stepwise multiple regression, only HOMA-S and WHR were retained in the model (R(2) = 0.294, P < 0.001). CONCLUSION: 17-OHPE exhibited different relationships with anthropometric, and biochemical parameters in PCOS patients, depending on the androgen levels. In PCOS subjects with high androgen concentrations, 17-OHPE was negatively associated with most anthropometric parameters, particularly with those used as markers of adipose tissue dysfunction and frequently employed as predictors of cardiovascular disease risk; otherwise, 17-OHPE was positively associated with HDL-C and HOMA-S in this patients. Future studies are required to evaluate the clinical implications of these novel findings. Bioscientifica Ltd 2017-08-07 /pmc/articles/PMC5592777/ /pubmed/28784626 http://dx.doi.org/10.1530/EC-17-0151 Text en © 2017 The authors http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research
de Medeiros, Sebastião Freitas
Ormond, Cinthia Marenza
de Medeiros, Matheus Antônio Souto
de Souza Santos, Nayara
Banhara, Camila Regis
Yamamoto, Márcia Marly Winck
Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title_full Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title_fullStr Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title_full_unstemmed Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title_short Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
title_sort metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592777/
https://www.ncbi.nlm.nih.gov/pubmed/28784626
http://dx.doi.org/10.1530/EC-17-0151
work_keys_str_mv AT demedeirossebastiaofreitas metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen
AT ormondcinthiamarenza metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen
AT demedeirosmatheusantoniosouto metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen
AT desouzasantosnayara metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen
AT banharacamilaregis metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen
AT yamamotomarciamarlywinck metabolicandendocrineconnectionsof17hydroxypregnenoloneinpolycysticovarysyndromewomen